Allogene Therapeutics, Inc.

ALLO - Company ID 0001737287

Market cap-

Rank-

Filings554

Allogene Therapeutics, Inc. has filed 554 public company documents between 2018 and 2026. The most frequent type is insider trade (234 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchALLO overviewCompany snapshotMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyLive rankingSee the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with AMGNPeer viewPut ALLO beside AMGN across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow ALLO via RSS

Similar companies to research next

AMGNAmgen Inc.

GILDGilead Sciences, Inc.AARGXargenx SE RRVMDRevolution Medicines, Inc.

BIIBBiogen Inc.

MRNAModerna, Inc.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
424B5	Prospectus supplement	2mo ago2026-04-15	-	View filing
424B5	Prospectus supplement	3mo ago2026-04-13	-	View filing
424B5	Prospectus supplement	2y ago2024-05-14	-	View filing
424B5	Prospectus supplement	2y ago2023-11-02	-	View filing
424B5	Prospectus supplement	6y ago2020-06-03	-	View filing
424B5	Prospectus supplement	6y ago2020-06-01	-	View filing

Allogene Therapeutics, Inc.

Similar companies to research next

Year